Category: Press Releases
Underdog Pharmaceuticals Receives Accelerated Designation
September 10, 2021
Underdog Pharmaceuticals (Now called Cyclarity Therapeautics) has just issued a press release announcing that UDP-003, a compound being studied for its effectiveness against oxidized cholesterol, has been given an Innovation
The Longevity Investors Conference
August 24, 2021
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 – The Longevity Investors Conference targets the
Underdog Pharmaceuticals Receives Accelerated Designation
September 10, 2021
Underdog Pharmaceuticals (Now called Cyclarity Therapeautics) has just issued a press release announcing that UDP-003, a compound being studied for its effectiveness against oxidized cholesterol, has been given an Innovation Passport under the UK’s Innovative Licensing and Access Pathway program. This is similar to the Fast
The Longevity Investors Conference
August 24, 2021
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 – The Longevity Investors Conference targets the global investor community and brings private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity